About » Office Locations » New England Division » New England News

Enfield Man Sentenced to 42 Months in Federal Prison for Selling Crack, Violating Supervised Release

NOV 26 (NEW HAVEN, Conn.) - John J. Arvanitis, Special Agent in Charge of the Drug Enforcement Administration for New England and Deirdre M. Daly, Acting United States Attorney for the District of Connecticut, announced that Nathan Snape, 37, of Enfield, was sentenced today by Chief U.S. District Judge Janet C. Hall in New Haven to 42 months of imprisonment, followed by five years of supervised release, for distributing crack cocaine and for violating the conditions of his supervised release from a previous federal conviction.

According to court documents and statements made in court, in December 2012, Enfield Police made three controlled purchases of crack cocaine from Snape.  On January 10, 2013, Snape was arrested at his Enfield apartment, where he was found in possession of an additional quantity of crack.

At the time of the offense, Snape was serving a period of federal supervised release stemming from a previous conviction for possession of a firearm by a convicted felon.  In 2003, Snape was sentenced to 84 months of imprisonment and three years of supervised release.  In 2011, he received an additional six months of imprisonment for violating the conditions of his supervised release.

On June 27, 2013, Snape pleaded guilty to one count of possession with intent to distribute cocaine base ("crack cocaine"), and he admitted to having violated the terms of his supervised release.

Judge Hall sentenced Snape to 24 months of imprisonment for the crack offense and a consecutive 18 months of imprisonment for violating his supervised release.

This matter was investigated by the Bureau of Alcohol, Tobacco, Firearms and Explosives, the Drug Enforcement Administration and the Enfield Police Department.


Receive E-mail Updates Receive E-mail Updates @DEAHQ Twitter Account button Hover @DEAHQ Twitter Account button Report Synthetic Drug Source button Hover Report Synthetic Drug Source button

Stay Connected Facebook Twitter YouTube


A-Z Index  Accessibility   Contact Us  FOIA  Legal Policies & Disclaimers  
No FEAR Act   Privacy Policy Plug-Ins Whistleblower Protection